Search Results - "MURPHY, W. K"

Report of a Consensus Conference on Transplant Program Quality and Surveillance by Kasiske, B. L., McBride, M. A., Cornell, D. L., Gaston, R. S., Henry, M. L., Irwin, F. D., Israni, A. K., Metzler, N. W., Murphy, K. W., Reed, A. I., Roberts, J. P., Salkowski, N., Snyder, J. J., Sweet, S. C.

“…Public reports of organ transplant program outcomes by the US Scientific Registry of Transplant Recipients have been both groundbreaking and controversial. The…”
Get full text

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer by Murphy, W K, Fossella, F V, Winn, R J, Shin, D M, Hynes, H E, Gross, H M, Davilla, E, Leimert, J, Dhingra, H, Raber, M N

“…Taxol, a complex plant product (a diterpene) extracted from the bark of Taxus brevifolia, has demonstrated substantial anticancer activity in ovarian and…”
Get more information

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer by Fossella, F V, Lee, J S, Shin, D M, Calayag, M, Huber, M, Perez-Soler, R, Murphy, W K, Lippman, S, Benner, S, Glisson, B

“…We conducted a phase II study to determine the response to and toxicity of docetaxel (Taxotere; Rhône-Poulenc Rorer Pharmaceuticals, Inc, Collegeville, PA) in…”
Get more information

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer by Fossella, F V, Lippman, S M, Shin, D M, Tarassoff, P, Calayag-Jung, M, Perez-Soler, R, Lee, J S, Murphy, W K, Glisson, B, Rivera, E, Hong, W K

“…We conducted a phase I trial of the novel nucleoside analog, gemcitabine, in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) to…”
Get more information

Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan by Perez-Soler, R, Glisson, B S, Lee, J S, Fossella, F V, Murphy, W K, Shin, D M, Hong, W K

“…This study was designed to assess the anti-tumor activity of topotecan (TPT) in patients with small-cell lung cancer (SCLC) refractory to etoposide…”
Get more information

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer by Fossella, F V, Lee, J S, Murphy, W K, Lippman, S M, Calayag, M, Pang, A, Chasen, M, Shin, D M, Glisson, B, Benner, S

“…We conducted a phase II study to determine the response and toxicity of docetaxel (Taxotere; Rhône-Poulenc Rorer Pharmaceuticals, Inc, Collegeville, PA) in…”
Get more information

Congenital absence of portal vein in the fetus: a case report by Venkat‐Raman, N., Murphy, K. W., Ghaus, K., Teoh, T.‐G., Higham, J. M., Carvalho, J. S.

“…Congenital absence of portal vein (CAPV) is a rare abnormality, which may be associated with other abnormalities. We report a case of prenatal diagnosis of…”
Get full text

A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis by Hesketh, P J, Harvey, W H, Harker, W G, Beck, T M, Ryan, T, Bricker, L J, Kish, J A, Murphy, W K, Hainsworth, J D, Haley, B

“…This study compares the efficacy and safety of ondansetron alone with that of ondansetron plus dexamethasone in the prevention of emesis induced by high-dose…”
Get more information

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy by Perez-Soler, R, Fossella, F V, Glisson, B S, Lee, J S, Murphy, W K, Shin, D M, Kemp, B L, Lee, J J, Kane, J, Robinson, R A, Lippman, S M, Kurie, J M, Huber, M H, Raber, M N, Hong, W K

“…This study was designed to assess the anti-tumor activity of topotecan (TPT) in patients with advanced non-small-cell lung cancer (NSCLC) previously untreated…”
Get more information

Increased first‐trimester fetal nuchal translucency thickness in association with chondroectodermal dysplasia (Ellis–Van Creveld syndrome) by Venkat‐Raman, N., Sebire, N. J., Murphy, K. W., Carvalho, J. S., Hall, C. M.

“…Increased nuchal translucency thickness (NT) is an established sonographic marker of fetal chromosomal abnormality. Several structural fetal defects and…”
Get full text

Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions by PEREZ-SOLER, R, SHIN, D. M, SIDDIK, Z. H, MURPHY, W. K, HUBER, M, JIN SOO LEE, KHOKHAR, A. R, HONG, W. K

“…cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) (NDDP) is a lipophilic non-cross-resistant platinum compound formulated in large…”
Get full text

Birth asphyxia and the intrapartum cardiotocograph by Murphy, K W, Johnson, P, Moorcraft, J, Pattinson, R, Russell, V, Turnbull, A

“…The intrapartum cardiotocographs (CTGs) of 38 severely asphyxiated, term infants, born during a 17-month period, and those of 120 healthy term infants acting…”
Get more information

Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting by Beck, T M, Hesketh, P J, Madajewicz, S, Navari, R M, Pendergrass, K, Lester, E P, Kish, J A, Murphy, W K, Hainsworth, J D, Gandara, D R

“…This study compares the efficacy and safety of two single-dose regimens with the approved three-dose regimen of ondansetron in the prevention of…”
Get more information

Cisplatin, Etoposide, and Paclitaxel in the Treatment of Patients With Extensive Small-Cell Lung Carcinoma by GLISSON, B. S, KURIE, J. M, SHIN, D. M, WAUN KI HONG, PEREZ-SOLER, R, FOX, N. J, MURPHY, W. K, FOSSELLA, F. V, LEE, J. S, ROSS, M. B, NYBERG, D. A, PISTERS, K. M. W

“…The combination of cisplatin, etoposide, and paclitaxel was studied in patients with extensive small-cell lung cancer in a phase I component followed by a…”
Get full text

Glucose Production by the Human Placenta in Vivo by Prendergast, C.H, Parker, K.H, Gray, R, Venkatesan, S, Bannister, P, Castro-Soares, J, Murphy, K.W, Beard, R.W, Regan, L, Robinson, S, Steer, P, Halliday, D, Johnston, D.G

“…The human placenta transports glucose by facilitated diffusion down a concentration gradient from mother to fetus. It has previously been considered incapable…”
Get full text

GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis by Hesketh, P J, Murphy, W K, Lester, E P, Gandara, D R, Khojasteh, A, Tapazoglou, E, Sartiano, G P, White, D R, Werner, K, Chubb, J M

“…We evaluated, in a multi-center trial, the safety and efficacy of GR 38032F (GR-C507/75), a novel and selective serotonin antagonist, in preventing acute…”
Get more information

Primary chemotherapy of brain metastasis in small-cell lung cancer by Lee, J S, Murphy, W K, Glisson, B S, Dhingra, H M, Holoye, P Y, Hong, W K

“…Fourteen patients with brain metastases from previously untreated small-cell lung cancer (SCLC) were treated with three courses of systemic chemotherapy as an…”
Get more information

The contribution of dystocia to the cesarean section rate by Macara, Lena M., Murphy, Karl W.

“…OBJECTIVE: Our purpose was to examine the indications for performing cesarean sections in current obstetric practice and to define and measure the true…”
Get full text

Delivery after caesarean section: Consultant obstetricians' professional advice and personal preferences by Sur, S., Murphy, K. W., Mackenzie, I. Z.

“…Summary The objective of this study was to determine how obstetricians would wish to be managed in their own pregnancy and their advice to patients delivering…”
Get full text

A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia by Warrell, Jr, R P, Murphy, W K, Schulman, P, O'Dwyer, P J, Heller, G

“…Hypercalcemia is a major source of morbidity and mortality in patients with cancer. Gallium nitrate and the bisphosphonate, etidronate, are new agents that…”
Get more information